Five-year outcomes of premature infants randomized to high or standard loading dose caffeine

Christopher McPherson1,2, Rachel E Lean3, Peppar E P Cyr4

  • 1Department of Pediatrics, Washington University in St. Louis, St. Louis, MO, USA. mcphersonc@wustl.edu.

Insights

A pilot study found that a high loading dose of caffeine citrate in very low birth weight neonates did not significantly impact 5-year neurodevelopment or socioemotional outcomes. Long-term follow-up showed no profound differences between high and standard dose groups.

Area of Science:

  • Neonatal Medicine
  • Developmental Pediatrics
  • Clinical Pharmacology

Background:

  • Preterm birth affects neurodevelopment.
  • Caffeine is used to treat apnea in preterm infants.
  • Optimal dosing strategies require investigation.

Purpose of the Study:

  • To assess 5-year neurodevelopmental and socioemotional outcomes.
  • To evaluate a high loading dose of caffeine citrate in very low birth weight neonates.
  • To inform optimal caffeine dosing in neonatal care.

Main Methods:

  • Pilot randomized controlled trial.
  • 74 very low birth weight neonates randomized to high (80 mg/kg) or standard (20 mg/kg) caffeine loading dose.
  • Standardized neurodevelopmental tests and parent reports at 5 years.

Main Results:

  • 74% of survivors returned for follow-up.
  • No significant differences in neurodevelopmental or socioemotional scores.
  • No difference in neurodevelopmental delay after controlling for confounders.

Conclusions:

  • High loading dose caffeine citrate did not profoundly impact 5-year outcomes.
  • This pilot trial suggests safety and efficacy of standard dosing.
  • Further research may explore individualized caffeine titration.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
19
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
8